603590.SHG Beijing Konruns Pharmaceutical Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
25.61 CNY
Close of Nov 5, 2026
24.06 48.44
Market cap
CNY 4.13B
P/E
29.8x
P/B
1.24x
ROE
4.2%
Dividend yield
2.48%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603590.SHG undervalued?

Graham number
Price25.61
Graham value19.99
Premium28.1%

603590.SHG trades 28.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Beijing Konruns Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Beijing Konruns Pharmaceutical Co Ltd yet.

Beijing Konruns Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Beijing Konruns Pharmaceutical Co Ltd

Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The company offers agkistrodon halys hemocoagulase under Suling trade name. It is also involved in the development of drug candidates, including ZY5301 that is in phase 3 clinical trials for the treatment of chronic pelvic pain in sequelae of pelvic inflammatory disease; and KC1036, which is in phase 2 clinical trial for the t…

Full company profile